- Combination of Methotrexate and Leflunomide for Adult-onset Still's Disease: A Case Report and Literature Review
-
Lee EE, Kim MJ, Song YW, Park JK
- KMID: 2471953
- J Rheum Dis.
- 2020 Apr;27(2):116-119.
- doi: 10.4078/jrd.2020.27.2.116
The treatment of adult-onset Still's disease (AOSD) aims to control systemic inflammation and prevent organ damage. Systemic inflammation can be controlled with corticosteroid (CS) monotherapy in most cases. However, symptoms... -
- CITED
-
- Close
- SHARE
-
- Close
- The Use of Biological Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in Korea: Results of a Korean Expert Consensus
-
Park EJ, Kim H, Jung SM, Sung YK, Baek HJ, Lee J
- KMID: 2471957
- J Rheum Dis.
- 2020 Jan;27(1):4-21.
- doi: 10.4078/jrd.2020.27.1.4
Biological disease-modifying antirheumatic drugs (bDMARDs) are highly effective agents for the treatment of inflammatory arthritis; however, they also possess a potential risk for serious infection. Recently, with the rapid expansion... -
- CITED
-
- Close
- SHARE
-
- Close
- A paradigm shift in studies based on rheumatoid arthritis clinical registries
-
Cho SK, Sung YK
- KMID: 2457019
- Korean J Intern Med.
- 2019 Sep;34(5):974-981.
- doi: 10.3904/kjim.2018.440
Clinical research is the study of aspects of patient health or illness that are closely related to clinical practice. In the late 20th and early 21th century, outcomes for patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis
-
Baek HJ, Lim MJ, Park W, Park SH, Shim SC, Yoo DH, Kim HA, Lee SK, Lee YJ, Park YE, Cha HS, Song YW
- KMID: 2457323
- Korean J Intern Med.
- 2019 Jul;34(4):917-931.
- doi: 10.3904/kjim.2017.159
BACKGROUND/AIMS: To investigate the efficacy and safety of tocilizumab (TCZ) humanized anti-interleukin-6 receptor monoclonal antibody, in Korean patients with active rheumatoid arthritis (RA) refractory to conventional disease modifying anti-rheumatic drugs... -
- CITED
-
- Close
- SHARE
-
- Close
- The Risk of Cardiovascular Disease and Diabetes in Rheumatoid Arthritis Patients: A Propensity Score Analysis
-
Rhew K
- KMID: 2452859
- Korean J Clin Pharm.
- 2019 Jun;29(2):109-114.
- doi: 10.24304/kjcp.2019.29.2.109
BACKGROUND: Rheumatoid arthritis (RA) is a systemic inflammatory disease that manifests as joint damage or athletic disability via sustained inflammation of the synovial membrane. The risk of cardiovascular disease (CVD)... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk of malignancy in patients with rheumatoid arthritis after anti-tumor necrosis factor therapy: results from Korean National Health Insurance claims data
-
Jung SM, Kwok SK, Ju JH, Park YB, Park SH
- KMID: 2448360
- Korean J Intern Med.
- 2019 May;34(3):669-677.
- doi: 10.3904/kjim.2016.374
BACKGROUND/AIMS: Inhibition of tumor necrosis factor (TNF) is an effective treatment for rheumatoid arthritis (RA), but safety concerns about malignancy remain. The aim of this study was to evaluate cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- The Risk of Malignancy in Korean Patients with Rheumatoid Arthritis
-
Lee H
- KMID: 2431640
- Yonsei Med J.
- 2019 Feb;60(2):223-229.
- doi: 10.3349/ymj.2019.60.2.223
PURPOSE: To investigate the overall cancer risk and risk for specific cancers in rheumatoid arthritis (RA) patients in Korea by comparing cancer incidence between RA patients and the general population. MATERIALS... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness and Safety of Tacrolimus in Patients with Active Rheumatoid Arthritis with Inadequate Response to Disease-modifying Anti-rheumatic Drugs: The TREASURE Study
-
Sheen DH, Hong SJ, Lee SH, Lee HS, Chung WT, Jiang H, Lee S, Yoo DH
- KMID: 2442031
- J Rheum Dis.
- 2019 Jan;26(1):20-30.
- doi: 10.4078/jrd.2019.26.1.20
OBJECTIVE: Evaluate effectiveness/safety of tacrolimus in patients in Korea with active rheumatoid arthritis (RA) and unsuccessful response to disease-modifying anti-rheumatic drugs (DMARDs). METHODS: Open-label, single-arm, non-comparative, 24-week, Phase-IV study in patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Treat-to-Target Strategy for Asian Patients with Early Rheumatoid Arthritis: Result of a Multicenter Trial in Korea
-
Song JJ, Song YW, Bae SC, Cha HS, Choe JY, Choi SJ, Kim HA, Kim J, Kim SS, Lee CK, Lee J, Lee SH, Lee SS, Lee SK, Lee SW, Park SH, Park W, Shim SC, Suh CH, Yoo B, Yoo DH, Yoo WH
- KMID: 2429601
- J Korean Med Sci.
- 2018 Dec;33(52):e346.
- doi: 10.3346/jkms.2018.33.e346
BACKGROUND: To evaluate the therapeutic benefits of the treat-to-target (T2T) strategy for Asian patients with early rheumatoid arthritis (RA) in Korea. METHODS: In a 1-year, multicenter, open-label strategy trial, 346 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Enthesitis-related Arthritis
-
Hahn YS
- KMID: 2429708
- J Rheum Dis.
- 2018 Oct;25(4):221-230.
- doi: 10.4078/jrd.2018.25.4.221
Enthesitis-related arthritis (ERA) is a disease predominantly affecting the joints and entheses of the lower extremities and has the potential to eventually affect the sacroiliac joints and spine evolving to... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk Factors Associated with Estimated Glomerular Filtration Rate in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis after Treatment with Biological Disease Modifying Anti-Rheumatic Drugs
-
Lee SW
- KMID: 2418435
- J Korean Med Sci.
- 2018 Jul;33(30):e214.
- doi: 10.3346/jkms.2018.33.e214
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Gender Is a Risk Factor for Annual Decline in Estimated Glomerular Filtration Rate in Patients Treated with Biological DMARDs in Rheumatoid Arthritis and Ankylosing Spondylitis: a Retrospective Observational Study
-
Kim SK, Choe JY
- KMID: 2418431
- J Korean Med Sci.
- 2018 Jul;33(30):e188.
- doi: 10.3346/jkms.2018.33.e188
BACKGROUND: This study identified the risk factors of changes in renal function in patients with rheumatoid arthritis (RA) and ankylosing spondylitis (AS) treated with biological disease-modifying anti-rheumatic drugs (bDMARDs). METHODS: We... -
- CITED
-
- Close
- SHARE
-
- Close
- Adult Stem Cell Treatment for Rheumatoid Arthritis
-
Jung SY
- KMID: 2415604
- J Rheum Dis.
- 2018 Jul;25(3):158-168.
- doi: 10.4078/jrd.2018.25.3.158
Since methotrexate began to be used in the treatment of rheumatoid arthritis (RA) 30 years ago, RA treatments have advanced rapidly from only reducing joint pain and inflammation to suppressing... -
- CITED
-
- Close
- SHARE
-
- Close
- Transaminase Changes in Korean Rheumatoid Arthritis Patients with Chronic Hepatitis C after Biologic Therapy
-
Kwon HM, Shin K, Moon JY, Lee SS, Chung WT, Lee J, Lee SH, Kang SW, Suh CH, Hong SJ, Song R, Choe JY, Song YW
- KMID: 2408928
- J Rheum Dis.
- 2018 Apr;25(2):108-115.
- doi: 10.4078/jrd.2018.25.2.108
OBJECTIVE: Coexisting chronic hepatitis C can be problematic when treating rheumatoid arthritis (RA). This study examined the changes in the transaminase and viral load in hepatitis C virus (HCV)-infected RA... -
- CITED
-
- Close
- SHARE
-
- Close
- Medication nonadherence in Korean patients with rheumatoid arthritis: the importance of belief about medication and illness perception
-
Suh YS, Cheon YH, Kim HO, Kim RB, Park KS, Kim SH, Lee SG, Park EK, Hur J, Lee SI
- KMID: 2411525
- Korean J Intern Med.
- 2018 Jan;33(1):203-210.
- doi: 10.3904/kjim.2015.383
BACKGROUND/AIMS: To investigate medication nonadherence in Korean patients with rheumatoid arthritis (RA) and analyze related factors. METHODS: A total of 292 patients with RA participated in this study. Medication nonadherence, intentional... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnosis and Treatment of Inflammatory Joint Disease
-
Kim Y, Oh HC, Park JW, Kim IS, Kim JY, Kim KC, Chae DS, Jo WL, Song JH
- KMID: 2424246
- Hip Pelvis.
- 2017 Dec;29(4):211-222.
- doi: 10.5371/hp.2017.29.4.211
Arthritis damages the cartilage within joints, resulting in degenerative changes, including loss of function and joint instability. Ankylosing spondylitis (AS) is a chronic inflammatory condition affecting the spine and bone-to-tendon... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk of Herpes Zoster in Patients with Rheumatoid Arthritis Undergoing Biologic Disease-Modifying Therapy
-
Kwon HM, Lee SJ, Yang JA, Choi Y, Park JK, Lee EY, Song YW, Lee EB
- KMID: 2389063
- J Rheum Dis.
- 2017 Aug;24(4):220-226.
- doi: 10.4078/jrd.2017.24.4.220
OBJECTIVE: Rheumatoid arthritis (RA) patients suffer from an increased risk of herpes zoster (HZ) partially due to immunosuppressant medications. This study investigated HZ in RA patients treated with biologic disease-modifying... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative efficacy of biological agents in methotrexate-refractory rheumatoid arthritis patients: a Bayesian mixed treatment comparison
-
Choi M, Hyun MK, Choi S, Tchoe HJ, Lee SY, Son KM, Kim MJ, Jung YO, Kim HA
- KMID: 2379485
- Korean J Intern Med.
- 2017 May;32(3):536-547.
- doi: 10.3904/kjim.2015.135
BACKGROUND/AIMS: Biological agents (biologics) targeting proinflammatory signaling have emerged as an important treatment option in rheumatoid arthritis (RA). Despite the clinical effectiveness of biologics for patients with RA who do... -
- CITED
-
- Close
- SHARE
-
- Close
- Auranofin Suppresses Plasminogen Activator Inhibitor-2 Expression through Annexin A5 Induction in Human Prostate Cancer Cells
-
Shin DW, Kwon YJ, Ye DJ, Baek HS, Lee JE, Chun YJ
- KMID: 2375038
- Biomol Ther.
- 2017 Mar;25(2):177-185.
- doi: 10.4062/biomolther.2016.223
Auranofin has been developed as antirheumatic drugs, which is currently under clinical development for the treatment of chronic lymphocytic leukemia. Previous report showed that auranofin induced apoptosis by enhancement of... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacologic treatment of rheumatoid arthritis
-
Cho SK, Bae SC
- KMID: 2368926
- J Korean Med Assoc.
- 2017 Feb;60(2):156-163.
- doi: 10.5124/jkma.2017.60.2.156
Rheumatoid arthritis (RA) is a systemic inflammatory disease that affects the joints. This chronic inflammatory condition causes joint destruction and functional disability, and reduces the quality of life of patients.... -
- CITED
-
- Close
- SHARE
-
- Close
